Companies: 10,795·Total market cap: $144.5T
ANI Pharmaceuticals, Inc.

ANI Pharmaceuticals, Inc.

ANIPNASDAQHealthcare● Active
$80.62
$-0.49(-0.60%)
Market Cap$1.8B
P/E Ratio
52W High$99.5
52W Low$59.61
Overview

ANI Pharmaceuticals, Inc.(ANIP)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · ANIP · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$0.88B$0.61B$0.49B$0.32B$0.22B
Cost of Revenue$0.43B$0.25B$0.18B$0.14B$0.10B
Gross Profit$0.45B$0.36B$0.31B$0.18B$0.12B
Gross Margin %(computed)51.01%59.27%62.71%56.13%53.45%
Operating Expenses
R&D Expenses$0.05B$0.04B$0.03B$0.02B$0.01B
G&A Expenses$0.00B$0.00B$0.00B$0.00B$0.00B
Total Operating Expenses$0.37B$0.36B$0.26B$0.21B$0.16B
Operating Income$0.08B$0.00B$0.05B($0.04B)($0.04B)
Operating Margin %(computed)9.20%0.10%9.65%-11.15%-18.41%
Interest Income$0.00B$0.00B$0.00B$0.00B$0.00B
Interest Expense$0.02B$0.02B$0.03B$0.03B$0.01B
Income Before Tax$0.10B($0.02B)$0.02B($0.06B)($0.06B)
Income Tax Expense$0.02B($0.00B)$0.00B($0.01B)($0.01B)
Net Income$0.08B($0.02B)$0.02B($0.05B)($0.04B)
Net Margin %(computed)8.87%-3.01%3.86%-15.14%-19.71%
Per Share & EBITDA
EPS (Basic)$3.50$-1.04$0.95$-3.05$-3.40
Wtd Avg Shares0.02B0.02B0.02B0.02B0.01B
EBITDA$0.21B$0.06B$0.11B$0.03B$0.00B
EBITDA Margin %(computed)23.46%10.27%21.90%7.91%1.44%

数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · B

深入了解ANI Pharmaceuticals, Inc.

关于ANI Pharmaceuticals, Inc.(ANIP)损益表

ANI Pharmaceuticals, Inc.(ANIP)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,ANIP实现营收$0.88B,毛利润$0.45B(毛利率51.01%),净利润$0.08B(净利率8.87%)。

常见问题

ANIP · 4 问

ANI Pharmaceuticals, Inc.(ANIP)2025财年营收为$0.88B,同比up43.8%。

ANIP revenueANIP salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08